Image of two people talking

The University of Kansas Medical Center is excited to announce we are now a site for the Alzheimer Biomarkers Consortium-Down Syndrome (ABC-DS).

The goal of ABC-DS is to follow a cohort of adults with Down syndrome over time to identify early biomarkers that may herald the onset of Alzheimer's disease.

These biomarkers are key to developing clinical trials and improving the quality of life in people with Down syndrome and for the general population.

Studies dedicated to those diagnosed with Down syndrome

DS Cohort

  • Participants must be18 years or older with DS
  • Long-term observational study
  • Three visitis every 16 months
Click Here to Learn More


  • Participants must be 25 - 55 years old with DS
  • No memory impairment
  • One visit every 16 months
Click Here to Learn More


  • Participants must be 18 years or older with DS
  • BMI of 25 or greater
  • Two visit observational study
Click Here to Learn More
Video about imaging for participants to watch prior to a study visit to see the process. 

Learn More about Research Opportunities 

Call 913.588.0555 option 1  

KU ADRC Down syndrome studies

Stay connected with us

Join MyAlliance for Brain Health

Join Today


NTG Down Syndrome and Dementia
NIH Alzheimer's Disease in People With Down Syndrome
CDC Down Syndrome and Increased Risk for Alzheimer's
Alzheimer's Association Down Syndrome and Alzheimer's Disease